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Introduction
The endothelial glycocalyx comprises a network of core proteins and branching glycosaminoglycan polymers such as heparan sulfate, chondroitin sulfate, and hyaluronans, that cover the luminal side of endothelial cells. The glycocalyx is essential to maintain integrity and function of the endothelial layer [1] [2] [3] . It serves as a receptor or co-receptor for various ligands such as growth factors, cytokines and chemokines, coagulation factors, proteases, complement-system proteins, membrane receptors, and adhesion proteins 4 .
Endothelial glycocalyx shedding occurs during many pathological conditions 5 , including cardiovascular, renal diseases 6, 7 and sepsis [8] [9] [10] . Heparan sulfate is a highly sulfated polysaccharide element of the endothelial glycocalyx. Experiments in gene-deleted mice showed that glycocalyx disturbances are not compatible with life. 11, 12 . The heparan sulfate interactome is formed by a 300-protein network 4 . Thus, degradation of heparan sulfate affects numerous cellular functions. The only known endo-β-D-glucuronidase capable of degrading heparan sulfate chains in mammals is heparanase 1 (HPSE1). HPSE1 is upregulated in many inflammatory diseases including cancer 13 , diabetes 14 , and sepsis 10 .
The Toll-like receptor-4 (TLR4) is an important inflammatory mediator 15 . Several reports addressed the role of heparan sulfate in the TLR4-mediated response. Soluble heparan sulfate chains serve as TLR4 ligands 16, 17 . Cleavage of heparan sulfate by HPSE1 strongly promoted TLR4 response in macrophages 18 . Furthermore, TLR4 signaling was inhibited in cells cultured on heparan sulfate proteoglycans-rich matrix. This inhibition was relieved by the matrix degradation 19 . However in microglia, overexpression of HPSE1 led to diminished LPS-induced response 20 . Co-localization of TLR4 co-receptor Cluster of Differentiation 14
(CD14) with heparan sulfate has been observed that let the authors to suggest that heparan sulfate promotes TLR4/CD14 association. In addition, it has been demonstrated that HPSE1
can act via TLRs causing pro-inflammatory response that is independent of catalytic activity 16, 21 .
McKenzie and colleagues cloned and characterized the Heparanase 2 (HPSE2) protein, that exhibits a 40% homology to HPSE1 22 . HPSE2 has no catalytic activity, but instead can inhibit HPSE1 23 . An antagonistic interaction of the heparanases in cancer have been recently reviewed recently 24 . Although HPSE2 circulates in the human plasma 13 , interactions between HPSE1 and HPSE2 in endothelial cells has not been investigated.
Endothelial cells express HPSE1 in vitro 25, 26 and serve as an important local source of HPSE1during inflammation 27 . We studied HPSE1 and HPSE2 in endothelial cells and animal models to elucidate the role of these enzymes in maintaining endothelial integrity Materials and methods.
1. Cells, antibody, Real Time-PCR.
Human microvascular endothelial cells line HMEC-1 was from ATCC. Cells were cultured as recommended by the supplier. Primary human dermal microvascular endothelial cells were from Promocell. Cells were cultivated as recommended by the supplier and used in the passage 4. Unless otherwise indicated, HMEC-1 cells were used through the study. The following antibodies were used: Heparan sulfate (clone 10e4) from Amsbio; HPSE1 (GTX32650) from GeneTex; Heparanase 2 (NBP1-31457) from Novus Biologicals were used for western blotting; 1c7 monoclonal blocking antibody to HPSE2 was a kind gift of Prof. I.
Vlodavsky; antibodies to HPSE2 purchased from Sigma (Cat. # HPA044603) were used for tissue staining; Tubulin (556321) from BD Pharmingen, P-p65 (93H1); P-p38 (D3F9), P-MEK (166M8), and cleaved Caspase 3 antibody (9665) were from Cell Signaling was perfused through the channels for 4 hrs. Cells were fixed by perfusion with 2% PFA and then stained.
Confocal microscopy was performed using Leica TCS-SP2 AOBS confocal microscope (Leica Microsystems). All the images were taken with oil-immersed x63 objective, NA 1.4.
Series of z-scans were processed and quantified using ImageJ software.
6. Biotin-LPS binding and pull-down assay.
Ultrapure biotin-LPS that activates only TLR4 pathway was purchased from InVivoGen. To analyze LPS binding, cells were placed on ice to prevent receptor internalization and incubated with 50ng/ml biotin-LPS for 1 h. Then cells were washed three times with 1% BSA in PBS and incubated with streptavidin-conjugated HRP on ice for 1 h. HRP activity was quantified using TMB substrate kit. Measurements were take using Tecan plate reader.
For pull down assay strepavidin-magnetic beads were used. Cells were incubated on ice with 50 ng/ml biotin-LPS. Then, the cells were placed at 37°C for indicated time to allow for activation of TLR4 signaling complex. Then cells were placed on ice, washed, and cell lysis was performed. Cell lysates were incubated with streptavidin-beads for 1h at 4°C on rotator, then washed three times with ice cold PBS and used for electrophoresis followed by immunoblotting.
Cell surface TLR4 ELISA.
Cell surface TLR4 expression was measured on live cells incubated on ice in buffer containing 0.5% BSA/PBS with 0.05% NaN 3 in ELISA plate 33 . Staining was quantified using HRP-antibody and TMB substrate kit.
8. Immunocytochemistry. After the stipulated time, cells grown on coverslips were fixed and processed for immunostaining as we have previously described 34 Polymicrobial sepsis in mice was induced by cecal ligation and puncture (CLP) as described previously 35 . Vehicle (PBS) or purified HPSE2 (100 µg in 50 µl) was administrated by intravenous injection 1h prior to CLP surgery. At 18 h after CLP or sham operation, mice were anesthetized with isofluorane for blood sampling. Subsequently animals were sacrificed and the kidneys were perfused with PBS solution via the left ventricle, removed, fixed in formalin for 24h, and processed for immunohistochemistry as described 35 .
Statistics.
We used mean ± SEM throughout this study. All experiments were repeated independently at least three times. For comparing two different groups of data, Student's T test test was applied. Multiple comparisons were analyzed by using the one-way analysis of variance with the Tukey as a post hoc test. "*" shows P value of less than 0.05; "**" shows P value of less than 0.01; "***" shows P value of less than 0.001. GraphPad Prism version 5.02
(GraphPad Prism Software Inc., San Diego, CA, USA) was used for data analysis.
Results

HPSE1 aggravates endothelial LPS responses
We first treated cells with purified catalytically active HPSE1 and then stimulated the cells with LPS. Immunocytochemical staining using monoclonal 10E4 antibody confirmed removal of heparan sulfate structures by HPSE1 ( Fig. 1A, B ). Cells treated with HPSE1 demonstrated morphological changes similar to the changes induced by LPS, namely cytoskeletal rearrangement and disruption of cell-cell contacts (Fig. 1C, D) . When HPSE1treated endothelial cells were stimulated with LPS, expression of IL-6 was significantly higher than in untreated cells ( Fig. 1E ). IL-6 was selected as a readout of the LPS-induced TLR4 response because IL-6 expression in endothelial cells was shown to be TLR4dependent 36 . In our experiments, the LPS-dependent expression of IL-6 was abrogated by the TLR4 inhibitor Cli-095 (data not shown). In a similar fashion, conditioned medium of the HPSE1-overexpressing endothelial cells that secrete the protein to the cell culture supernatant also promoted the LPS response in comparison to conditioned medium of the cells infected with control virus (Fig. 1F ). This data showed that catalytic activity of HPSE1 promotes the LPS response in endothelial cells.
Endothelial cells can serve as a source of HPSE1 26 . HPSE1 is expressed in the form of 65 kD inactive precursor that is processed to an active 50 kD isoform through cleavage by Cathepsin L (Ctsl) 6 . To assess whether or not endogenous HPSE1 is activated by LPS in endothelial cells, we analyzed the expression of both HPSE1 isoforms in the conditioned medium of cells and cell lysates using antibody that recognizes both forms. We found 65 kD inactive HPSE1 mainly in cell conditioned medium, whereas active 50 kD form was mostly associated with the cells. Furthermore, the content of the endogenous catalytically active 50 kD HPSE1 was time dependently increased after the LPS treatment ( Fig. 1G-E) whereas the content of 65 kD isoform in the conditioned medium was decreasing. These data point that endogenous HPSE1
can be activated after LPS treatment to provide for a positive TLR4-signaling feedback loop.
HPSE2 overexpression protects from heparan sulfate-glycocalyx shedding
To visualize the role of both heparanases in the turnover of the heparan sulfate glycocalyx in the endothelial cells, we established overexpression of HPSE2 through lentiviral transduction (Suppl. Fig. S1A -C). Similar to the endogenous HPSE2, overexpressed protein was released from the cells and distributed between free soluble form in the conditioned medium and cellsurface bound form (Suppl. Fig. S1B , C). HPSE-2 overexpressing endothelial cells showed no signs of toxicity. Instead, proliferation rate was slightly increased and the cells were protected against the TGFβ-induced apoptosis (Suppl. Fig. S1D , E).
We next inspected HPSE2-overexpressing endothelial cells that were incubated in the Polydimethylsiloxan (PDMS) -microfluidic chips under medium flow conditions. The chips consisted of 4 parallel 10 mm-long and 2 mm-wide channels ( Fig. 2A ). The cells were incubated under permanent medium flow conditions for 3 days. Endothelial cells developed a more 3D heparan sulfate-enriched glycocalyx layer when were subjected to the medium flow ( Fig. 2B ). Orthogonal views of the 3D z-scans confirmed extracellular localization of the glycocalyx layer above the layer of cell nuclei (Fig. 2B ). We then added catalytically active HPSE1 to the medium used for chips perfusion. Under flow conditions this treatment also led to the shedding of heparan sulfate layer from the cell surface ( Fig. 2C, D) . Remarkably, cells overexpressing HPSE2 were protected against glycocalyx shedding by the exogenous HPSE1 Confirming inhibitory role of heparan sulfate on the TLR4 response, the cells cultured under flow conditions demonstrated strongly diminished response to LPS (Fig. 2E ). The expression of HPSE1 in endothelial cells cultured under flow was also diminished (Suppl. Fig. S2B ).
To assess whether or not HPSE2 prevents also the activity of endogenous HPSE1, lentivirusinfected cells were stimulated with LPS and activation of HPSE1 was followed by the accumulation of the active 50 kD HPSE1 isoform (Fig. 2F, Suppl. Fig. S1F ). The overexpression of HPSE2 not only prevented the activity of exogenous HPSE1, but also LPSdependent increase of endogenous HPSE1 activity. This data confirmed antagonistic relationship between the heparanases in endothelial cells. Accordingly, both expression and activity of Ctsl in the HPSE2 overexpressing cells were slightly decreased (Supp. Fig. S2B , C).
HPSE2 protects endothelial cells
We next studied whether or not HPSE2 can also exert protective functions under pathological situations. Control and HPSE2-overexpressing endothelial cells cultured under static conditions were treated with different concentrations of LPS. Significant downregulation of the LPS-induced IL-6 expression was observed in the HPSE2-overexpressing endothelial cells at different LPS concentrations (Fig. 3A) . To precisely characterize the LPS response in HPSE2 overexpressing cells, Human Common Cytokine RT 2 Profiler Array was performed.
Expressions of several pro-inflammatory cytokines, in particular, IL-6, IFNB1, IFNA1, CSF3
(G-CSF), and TNFSF10 were significantly downregulated in HPSE2-overexpressing cells (Suppl. Fig. S3A ). The data of the array were verified in independent RT-PCR experiment Further cytokines including CSF2, IL-1A, IL-1B, TGFB3, TNFRSF11 were downregulated to a lesser degree. Together, these data demonstrated general antiinflammatory effects of the HPSE2 overexpression in the endothelial cells. The overexpression of HPSE2 have not induced any inflammatory effect on endothelial cells.
We then assessed morphological changes in the endothelial cells treated with LPS. Similar to data reported by Zheng et al. 37 , we observed that control cells treated with 100 ng/ml LPS lost cell-cell contacts and demonstrated decreased VE-Cadherin protein expression ( Fig. 3B, C) , while HPSE2-overexpressing cells were protected and preserved cell-cell contacts much better than control cells. These cells also demonstrated increased VE-Cadherin expression after the LPS treatment ( Fig. 3D ). LPS-induced protein phosphorylation and activation of NFκB were less activated in HPSE-2 overexpressing endothelial cells as determined by western blotting (Fig. 3E , F) and luciferase assay (Suppl. Fig. S2E ). Together, these data demonstrated a strong protection of endothelial cells exposed to LPS by HPSE2.
HPSE2 prevents HPSE1 activity
To test this idea, we made use of OGT 2115, an inhibitor of HPSE1 catalytic activity. The compound decreased NFκB activation as shown in promoter activity luciferase assay (Suppl. Fig. S2E ). LPS-dependent expression and secretion of IL-6 was accordingly downregulated in the presence of HPSE1 inhibitor (Fig. 4A, B ). However, there was no additive effect after HPSE1 inhibition in HPSE2 overexpressing cells ( Fig. 4A, B ; Suppl. Fig. S2E ). This finding suggested that both proteins are parts of the same molecular pathway and anti-inflammatory role of HPSE2 is most likely mediated by its antagonistic action on HPSE1. A specific protective role of HPSE2 was further confirmed using the 1c7 antibody to HPSE2 23 that can block HPSE2 interaction with heparan sulfate 38 . Application of the 1c7 antibody and thus displacement of the protein from cell surface heparan sulfate glycocalyx structures resulted in 16 abrogation of HPSE2 protective action and strong activation of LPS response (Fig. 4C ). We suggest that HPSE1regulates TLR4 response in endothelial cells. The effects are counteracted by HPSE2 bound to cell surface heparan sulfate.
HPSE2 inhibits LPS binding to TLR4 receptor complex
We next studied the mechanisms of the regulation of LPS response in endothelial cells by HPSE1. Molecular mechanisms of TLR4 signaling are extensively investigated. The LPS molecule is first bound to TLR4 co-receptor, CD14 39 . Thereafter, LPS is transferred to the complex of TLR4 with an accessory molecule, Lymphocyte antigen 96, (also known as MD2) to induce the activation of intracellular adapters and subsequent protein phosphorylation cascades 40 . Several mechanisms could account for the role of HPSE1. First, TLR4 can be further activated by heparan sulfate fragments originating from the HPSE1 catalytic activity 16 . Second, LPS ligand binding to the CD14 receptor could be affected by heparan sulfate. Finally, the interaction of TLR4 with co-receptors on the cell membrane can be regulated by heparan sulfate. We first tested whether accumulation of heparan sulfate fragments during the cells stimulation with LPS can lead to further activation of TLR4.
Exogenous heparan sulfate caused a weak increase in IL-6 expression, even at high concentrations (Fig. 5A ). This response was also decreased in HPSE2-overexpressing cells ( Fig. 5A ). To investigate whether or not endogenously produced soluble heparan sulfate fragments can promote TLR4 activation, conditioned medium of cells treated with LPS for 3 h, was used for stimulation of naïve cells. We found that supernatant of LPS-treated cells caused strong increase of IL-6 expression ( Fig. 5B) . Proteinase K is a serine protease used to 24 expression ( Fig. 5B ). Exogenous heparan sulfate at concentration of 100 ng/ml strongly potentiated endothelial cell response to LPS (Fig. 5C ). This response was documented by the 3-folds increase of the LPS-induced IL-6 expression in the presence of exogenous heparan sulfate. These findings suggested that concentration of endogenous heparan sulfate fragments produced during 3 hrs of LPS stimulation was not sufficient to potentiate activation of TLR4.
However, in the case of significant accumulation, soluble heparan sulfate fragments can potentiate inflammatory response of endothelial cells to LPS.
We then investigated whether HPSE2 can affect LPS binding using biotin-LPS. Cells were incubated on ice to prevent internalization of receptors. Cell binding of biotin-LPS was not decreased by overexpression of HPSE2 ( Fig. 5D ), suggesting that LPS binding to CD14 was not affected. The specificity of biotin-LPS binding to CD14 was confirmed by application of CD14 blocking antibody. Over 70% of the Biotin-LPS binding was blocked by CD14 antibody but not isotypic IgG.
TLR4 intracellular signaling is mediated by the recruitment of two adapter proteins, MyD88
and TIR-domain-containing adapter-inducing interferon-β (TRIF) 41 . We observed diminished LPS-induced expression of IL-6 suggesting impaired MyD88-pathway activation in HPSE2overexpressing cells. We further investigated the expression of IFNB1 and chemokine ligand-5 (CCL5), also known as RANTES that is mediated by TRIF adapter pathway activation ( Fig.   6A ). Our data show that both, MyD88 and TRIF-mediated signaling pathways of TLR4 are inhibited by HPSE2. Since LPS binding was not impaired by the overexpression of HPSE2, we reasoned that HPSE2 most likely interfered with the LPS transfer from CD14 to TLR4/MD2 complex. In order to verify this hypothesis, a pull-down assay using biotin-LPS and streptavidin magnetic beads was performed. Cells were incubated for 1 h on ice in the presence of 50 ng/ml biotin-LPS to allow its binding to the cell surface. Then, the cells were transferred to 37°C for the indicated time to enable further signaling events to take place.
The results supported our hypothesis ( Fig. 6B, C) as less TLR4 was detected in the biotin-
LPS complexes from HPSE2-overexpressing endothelial cells. Regulation of CD14/TLR4
association by HPSE1 and protective role of HPSE2 was confirmed by the Duolink proximity ligation assay -a method to detect protein-protein interaction (Fig. 6D, E) . To investigate the endocytosis of TLR4, cell surface staining on living cells was performed. To stop endocytosis and prevent staining of intracellular TLR4, cells were placed on ice after LPS stimulation and stained with anti-TLR4 antibody (Fig. 6F, G) . Decreased staining suggested active endocytosis of the receptor complex in control cells. However, in HPSE2-overexpressing cells TLR4 remained on the cell surface. These findings imply that membrane-bound heparan sulfate prevents LPS transfer from CD14 to TLR4/MD2 complex and its removal by HPSE1
promotes the LPS response of endothelial cells.
HPSE2 is protective in vivo
To investigate how expression of endogenous HPSE2 is regulated during sepsis, we used the mouse CLP polymicrobial sepsis model. We observed decreased HPSE2 expression in serum of CLP mice (Fig. 7A, B ). In the kidney we observed HPSE2 expression in medullary capillaries. This expression of HPSE2 was strongly downregulated in sepsis (Fig. 7C, D) .
Negative control staining is shown in supplementary Fig. S3F .
We next purified HPSE2 from conditioned medium of HEK293T cells transduced with LV-HPSE2 overexpression virus. Application of the exogenous HPSE2 diminished LPS response of the endothelial cells in vitro in a similar fashion to HPSE2 overexpression ( Supplementary   Fig. S3G ). When co-injected intravenously along with LPS in mice, HPSE2 had similar protective effects and caused statistically significant decrease in the plasma content of TNFα and IL-6 2 h after injection (Fig. 7E, F) . This data suggest that HPSE2 has also an endothelial protective function in microvasculature in vivo and can have some therapeutic potential.
Discussion
We demonstrated an important protective role for HPSE2 both in vivo and in vitro. Using different approaches we showed that HPSE1 activity aggravates endothelial response to LPS, whereas HPSE2 prevents activation of HPSE1, heparan sulfate shedding, and inflammatory responses mediated by TLR4. Our findings support an essential role for an intact glycocalyx in the endothelium. Glycocalyceal shedding occurs in many diseases and pathological insults.
However, the mechanisms how glycocalyceal turnover is regulated and what the consequences are when the process is perturbed is still imperfectly understood. A high expression of HPSE1, the sole enzyme capable of cleaving heparan sulfate, is damaging for the endothelium 42 . Although the role of HPSE2 as an antagonist of HPSE1 is well appreciated in cancer, how the interaction of these proteins can affect endothelial cells is less clear.
The role of heparan sulfate in the TLR4-mediated LPS response is not well understood.
Soluble heparan sulfate fragments generated by HPSE1 can serve as ligand for TLR4 16 .
Treatment of macrophages with HPSE1 facilitated an inflammatory response. On the contrary, in microglia heparan sulfate promoted TLR4/CD14 complex formation and HPSE1 transgenic cells showed less inflammatory response to LPS 20 . Our data suggest that heparan sulfate prevents the activation of TLR4 signaling and inflammatory response of endothelium.
HPSE1 is an important component of the TLR4 signalosome as heparan sulfate cleavage facilitates cellular response and promotes inflammatory reaction of the endothelial cells.
Both heparanases are present in human plasma. HPSE1 upregulation is associated with many disease states. Our data showed decreased plasma HPSE2 expression in mouse sepsis models indicating that cross-talk of the heparanases is important in vivo. Our data suggest that endothelial cell express and release HPSE1 and HPSE2 for local regulation of heparan sulfate turnover. Our mechanistic studies showed that HPSE2 bound to heparan sulfate on the endothelial cell surface prevents activation of HPSE1 and heparan sulfate shedding. We found that HPSE2 displacement from the cell surface by the 1c7 antibody 38 In macrophages HPSE1 itself was shown to induce TLR dependent signaling 21 . In endothelial cells HPSE1 induced rather weak inflammatory response by itself and only by the prolonged incubation (data not shown). Thus, in the context of TLR4 activation on the endothelium, remodeling of the glycocalyx on the cell surface seems more important. Interestingly, exogenous heparan sulfate strongly potentiated cell response to LPS. The finding can probably be explained by competitive binding of HPSE2 to soluble heparan sulfate resulting in its' removal from the cell membrane-associated glycocalyx.
We used biotin-LPS to demonstrate that HPSE2 does not interfere with LPS binding to the CD14 but rather prevents LPS transfer to TLR4 and activation of the cellular signaling. As a result, the inflammatory response was reduced. Early reports suggested that endothelial cells express only the soluble form of CD14 45, 46 . On the contrary, more recent reports showed the 48 . We showed that both, MyD88-and TRIF-dependent pathways are affected by HPSE2. Therefore, we assume that membrane bound form of CD14 is regulated by heparan sulfate. However, involvement of soluble CD14 can not be excluded.
In vivo co-injection of HPSE2 along with LPS in mice led to decreased cytokines expression in plasma. In polymicrobial CLP mouse sepsis model the expression of HPSE2 in renal medullary capillaries was decreased. Thus, loss of HPSE2 can promote microcirculatory disorder in sepsis leading to organ failure.
Our results suggest that HPSE2, expressed locally by the endothelial cells or delivered with blood, fulfills protective role in microvasculature via protection from heparan sulfate shedding and anti-inflammatory regulation of TLR4 signaling. HPSE2 is a novel molecule which exerts a direct protective effect on the endothelial glycocalyx thereby maintaining microvascular function and stability as well as protecting the endothelium from damage. Our results in vivo suggest that HPSE2 supplementation may be beneficial for the protection of the microvasculature. This novel mechanism supports therapeutic strategies to stabilize the endothelial glycocalyx.  Expression of HPSE2 in vivo is decreased in sepsis. 28 
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LV-HPSE2 over Figure 5 . Heparan sulfate fragments cause weak activation of endothelial cells. A. Endothelial cells were treated with the indicated concentration of heparan sulfate (HS) for 3 hrs. IL-6 expression was assessed by RT-PCR. B. Conditioned medium of endothelial cells treated for 3 hrs with 100 ng/ml and 500 ng/ml LPS was used for stimulating naïve cells. Conditioned medium was treated with Proteinase K immobilized on agarose beads and remaining LPS was removed by incubation with LPS removal beads, as indicated. IL-6 expression was assessed by RT-PCR. C. Endothelial cells were stimulated with 100 ng/ml LPS in the absence and in the presence of 100 ng/ml heparan sulfate (HS). D. Cell-based ELISA for Biotin-LPS binding. Lentivirus-transduced endothelial cells were incubated on ice for 1h in the presence of biotin-LPS as indicated. After washing cells were incubated with SV-HRP. Biotin-LPS binding was quantified using TMB substrate kit. Figure 6 . HPSE2 overexpression prevents TLR4 activation by LPS. A. Endothelial cells infected with Control and HPSE2 overexpression lentivirus were treated with 100 ng/ml LPS for 3 hrs. Expression was analyzed by TaqMan RT-PCR. B. TLR4 pull-down using biotin-LPS was performed as described in the Materials and Methods section. TLR4 was detected by immunoblotting. C. Quantification of independent TLR4 pull-down assay experiments. D. Duolink proximity ligation assay revealing direct interaction of TLR4 and CD14 was performed on endothelial cells stimulated with 100 ng/ml LPS for 20 min. Treatment with catalytically active HPSE1 was performed for 1 h prior to LPS stimulation. E. Duolink signal stained as in F was quantified using ImageJ as described in Materials and Methods. F. To detect cell surface TLR4 lentivirus-infected endothelial cells were stimulated with 500 ng/ml LPS for 1h, then placed on ice and incubated with TLR4 antibody. Then, the cells were washed, fixed, and stained with secondary antibody (green) and DAPI. G. Cell surface TLR4 expression of lentivirus-infected and LPS-stimulated endothelial cells was quantified using cell-based ELISA as described in Materials and Methods. 
